Uterine Cancers Information and Resources
Fund Status and Eligibility
Fully Allocated - Effective 02/07/2019, we are unable to process applications that are pending or accept new or renewal applications at this time. Should additional funding for Uterine Cancers Fund applicants become available in the future, it will be necessary to re-apply if assistance is still needed.
Maximum Award Level: $3,500 Per Year
- Patient must be insured and insurance must cover the medication for which patient seeks assistance.
- Patient must have a confirmed diagnosis of cancer occurring in the uterus.
- Patient must reside and receive treatment in the United States.
- Patient's income must fall below 400% of the Federal Poverty Guideline (FPG) with consideration of the Cost of Living Index (COLI) and the number in the household.
Get Help With Your Treatment: How to Apply Online
Information About the Disease
There are many types of uterine cancer and this fund covers any cancer occurring in the uterus. There are two main groups of uterine cancer:
Endometrial cancer - cancer that begins in cells lining the uterus. When cancer forms in the lining or mucus-secreting glands of the uterus, it is referred to as endometrial cancer. The majority of cancers of the uterus are endometrial cancers. Endometrial cancers may include but are not limited to the following types and alternative names: endometrial carcinoma, endometrial adenocarcinomas, uterine carcinomas, uterine carcinosarcomas, uterine adenocarcinomas, epithelial malignant neoplasms or malignant mixed mesodermal tumors.
Uterine sarcoma - cancer that begins in muscle or other tissues in the uterus. Uterine sarcoma forms in the muscle, connective tissue or supportive tissues of the uterus.
Types of uterine sarcoma are:
Uterine leiomyosarcoma - cancer that affects smooth muscle tissue. These tumors are most common in the abdomen, but can occur anywhere in the body, including the uterus.
Endometrial stromal sarcoma - starts in the connective tissue that supports the endometrium (endometrial stroma). Additional uterine sarcomas may include but are not limited to the following types and alternative names: carcinosarcoma, endometrial stromal sarcoma, undifferentiated sarcoma, adenosarcoma, adenosarcoma with sarcomatous overgrowth, perivascular endothelial cell tumor (PEComa), mesenchymal tumors, undifferentiated endometrial sarcomas, smooth muscle tumors of uncertain malignant potential; Müllerian adenosarcomas, carcinofibromas, adenofibromas, and adenomyomas, uterine carcinosarcoma, mixed mesodermal tumor, uterine papillary serous carcinoma, and clear cell carcinoma.
Foundation for Women’s Cancer
Phone: 1-312-578-1439 - https://www.foundationforwomenscancer.org/
American Cancer Society
Phone: 1-800-227-2345 - https://www.cancer.org/cancer/endometrial-cancer
Phone: 1-888-651-3038 - https://www.cancer.net/
National Cancer Institute
Phone: 1-800-422-6237 - https://www.cancer.gov/types/uterine/research
The American College of Obstetricians and Gynecologists
The Patient Advocate Foundation's (PAF) Co-Pay Relief (CPR) Program does not review the information contained on the website links provided for content, accuracy or completeness. Use of and access to this information is subject to the terms, limitations and conditions as outlined on the accessed websites.
PAF Co-Pay Relief Program makes no representation as to the accuracy or any other aspect of the information contained on any website accessed from the CPR website, nor does PAF Co-Pay Relief Program necessarily endorse the website information provided.
The information presented on the PAF Co-Pay Relief website is provided for general information only and is not intended as a substitute for medical care. Please talk with your healthcare provider about any information you acquire from this or any other website accessed through the PAF Co-Pay Relief program website.